Noetix Robotics Files Confidentially for Hong Kong IPO, Backed by CATL
Noetix Robotics has taken a step toward a Hong Kong listing. Bloomberg reported on Oct. 22 that the Beijing-based humanoid robot company filed a confidential IPO application with the Hong Kong Stock Exchange, with fundraising potentially reaching hundreds of millions of dollars and a listing as early as 2027.
Hong Kong media outlets including Hong Kong Economic Times and Ta Kung Pao followed up on Oct. 23, placing the Tsinghua-linked company—known for its “sub-RMB 10,000” humanoid robots—on the city’s IPO watch list. The company has not publicly disclosed the filing’s size or timetable.
The confidential route keeps key details out of public view for now, but the move formally puts Noetix on the path to public markets.
A confidential filing is itself a signal. Unlike a standard IPO, the mechanism lets a company withhold prospectus details—financials, shareholding structure and risk factors—until it clears the exchange’s initial review. For now, the market can see only the funding trail and product narrative, not a fully auditable financial picture.
Noetix has taken a path opposite to many peers. While several humanoid robot companies start with industrial or commercial service scenarios, the company, founded in September 2023, has bet on the consumer market. In October 2025 it launched Bumi, a bipedal humanoid priced at RMB 9,998, bringing a humanoid robot below the RMB 10,000 threshold for the first time.
Bumi uses composite materials instead of metal, preserving 21 degrees of freedom and high dynamic motion performance while pushing costs below what metal-based designs can easily match. In the 2026 CCTV Spring Festival Gala, a bionic Bumi robot appeared in a sketch with comedian Cai Ming, sharply raising brand awareness. Noetix quickly topped JD.com’s humanoid robot category in sales, and offline orders reportedly multiplied from pre-holiday levels.
Turning Spring Festival traffic into a sustainable commercial loop hinges on delivery. Founder Jiang Zheyuan has set a 2026 target of 10,000-unit deliveries for Bumi. That is a hard threshold for humanoids: a single robot contains hundreds to thousands of parts, and a shortage of any component can stall an entire production line. Once monthly output climbs to 1,000–2,000 units, quality control and workforce management pressures rise exponentially.
Noetix says daily capacity has reached dozens of units, still a significant climb from the annual 10,000-unit goal. Whether it can complete that ramp will determine whether Hong Kong investors see “a consumer robot company with orders” or “a prototype company with a story.” The founder’s target underscores the gap between demo videos and mass manufacturing.
On the funding side, Noetix closed nearly RMB 1 billion in Series B financing in March 2026, led by Chendao Capital, an industrial investment platform tied to CATL, with participation from Guoke Investment, Jingguosheng Fund and Jiuhe Ventures. The round valued the company at about US$550 million. Jiang, born in 1998, dropped out of a PhD program in Tsinghua’s electronics department to start the company. Noetix has raised more than US$200 million across nine rounds, moving from a RMB 50 million first-round valuation to unicorn ranks in under three years.
Seen in a broader context, Noetix’s filing lands at a delicate moment for the humanoid robot Hong Kong IPO window. UBTech is already listed in Hong Kong with a market value of around HK$45 billion. Zhiyuan Robotics began Hong Kong preparations in July 2026, but its plan to list within the year has largely fallen through; 2027 is now the earliest likely timetable.
By taking a confidential “placeholder” position now, Noetix avoids premature scrutiny over financial details while sending primary-market investors a clear signal about exit expectations. The listing window is narrowing as investors weigh commercialization progress.